Excitement is building up for the International Society for Stem Cell Research (ISSCR) annual meeting next week in Hamburg, Germany! Look out for the team below and do not hesitate to connect with them to have fascinating discussions on our lead program in Parkinson’s disease and our transformational technology, C-Stem™. You can also find them at the following events: Poster Presentation: #190 Clinical Applications (CA) Session Presenter: Maxime Feyeux Wednesday, July 10, 2024 @ 6:45 PM – 7:45 PM Room: Poster & Exhibit hall Innovation Showcase Presenters: Maxime Feyeux, Joffrey MIANNE, Clément Rieu Thursday July 11th, 2024 @ 6:00PM – 6:30PM Room: Hall 3, entrance level #ISSCR2024 #CellTherapyForAll
TreeFrog Therapeutics’ Post
More Relevant Posts
-
Tic tac, Tic Tac! Only 1 Day before the AD/PD International Conference in Lisbon. An opportunity to discover our lastest results on Alzheimer's Disease throught our poster. Thanks to Dr. Ahmad ALLOUCHE for this presentation (which will be fascinating, no doubt!). ETAP-Lab - Preclinical CRO Thibault Honegger Nicolas Violle #neurodegenerative #neuroscience #organsonchip #drugdevelopment
🧠 March 5-9 - Lisbon - AD/PD International Conference | Explore the research findings of ETAP-Lab and NETRI from the BIO-Diamond project at the poster titled :Advancing Alzheimer's Disease Models for Target Validation and Drug Discovery. 🔬 Meet our expert, Dr. Ahmad ALLOUCHE, and learn more about this project. 💡 We are proud to present our innovative #BrainOnChip model designed to develop and explore drug efficacy in #Alzheimer's disease. Our model incorporates: > Compartmentalized co-culture, showcased in the poster, featuring glutamatergic and GABAergic neurons derived from human induced pluripotent stem cells (hiPSCs). > Fluidic isolation using NETRI's #DuaLink device and #DuaLinkMEA device (MicroElectrodeArray). > Integration of ETAP-Lab's toxic oligomeric forms of human amyloid beta 1-42 (AβO). For poster reprint >> https://lnkd.in/ecbay2p2 Interested in scheduling a meeting with Dr. Allouche? Email us at: >> contact@etap-lab.com Don't forget to subscribe for updates to stay informed about our latest developments. This project is proudly funded by the French Government with “France 2023” under the call for proposals “Innovations in biotherapies & bioproduction”. We look forward to seeing you in Lisbon! Laura Ejarque | Thibault Honegger | Benoît Maisonneuve - PhD | Julie Colin | Louise Miny | Jessica Rontard, PhD | Nicolas Violle #ADPD2024 #AlzheimersResearch #DrugDiscovery
To view or add a comment, sign in
-
-
🔎 Join Dr. Fabiana Bressan, GFI grantee & associate professor at the University of São Paulo (USP - Universidade de São Paulo), on April 18 for a deep dive into how leveraging induced pluripotent stem cells can advance #cultivatedmeat production. Register here 👉
To view or add a comment, sign in
-
-
Working with stem cells? Interested on standards? Then join us tomorrow to learn from internationally renowned speakers discussing on “The Use of Standards for Stem Cells on Non-Clinical Research” at 1:30pm ar Hall G2, Level 2 #ISSCR2024
Are you passionate about advancing the field of stem cell research? 📣 Then join us for a stimulating panel discussion on "The Use of Standards in Stem Cells for Non-Clinical Research" at ISSCR 2024, on Friday 12th July at 1:30pm Hall G2, Level 2. 🎤 Event co-organised by European Commission Joint Research Centre. 🌍 Lucia Selfa Aspiroz, PhD, Glyn Stacey, Mark Kotter, Martin Pera, Christine Mummery, Carlos Tristan, Maurice Whelan, Debora Valsesia, Eva Åhs Lopez, Stéphanie Laduron, Ciarán NICHOLL #EU #Standards #StemCell #NonClinicalResearch #ECVAM #Science4Policy #3Rs #NonAnimalMethods #ISSCR2024
To view or add a comment, sign in
-
Last week, RegMed XB had the pleasure of joining an insightful event hosted by the Novo Nordisk Foundation Center for Stem Cell Medicine – reNEW at Leiden University. Our Business Developer, Dominique de Jong, took the stage as a guest speaker, offering a thought-provoking talk titled 'Basics of Valorization and Why Industry Is Not the Devil'. In her presentation, she delved into the essentials of #valorization. Other inspiring speakers who enriched the program were: Conor Simpson from Luris, explaining how LURIS can assist in creating impactful outcomes. Melissa Van Pel from NecstGen, delving into translational considerations for future cell therapy process development. The event proved to be an engaging day aimed at informing researchers about tech transfer. Topics included, for example, what researchers can do to ensure that tech transfer remains a possibility, which forms of valorization are most common, and what influence that has on the position and freedoms of the researcher, as well as which steps researchers can take in a preclinical stage to ensure that a cell therapy can be translated into a GMP-grade protocol. We're grateful for the opportunity to contribute and extend our appreciation to the ReNEW consortium for organizing this informative event. Let's continue working together to pave the way for groundbreaking advancements in regenerative medicine and beyond! #TechTransfer #Valorization #RegenerativeMedicine #Innovation #Preclinical
To view or add a comment, sign in
-
🔬Check out our chapters on Manufacturing an Adipose-Derived Hydrogel and Quality Control Assessment of Human Adipose-Derived Hydrogels! They include useful information on how to characterize hydrogels with commercially available assays which saves you time and streamlines your processes.
🚨 PUBLICATION ALERT 🚨 Explore our latest publication featuring cutting-edge protocols for adipose-derived stem cell applications, meticulously developed by our distinguished team at Obatala in collaboration with industry leaders. Elevate your research and innovation journey with insights from our experts. Dive in now! Thank you to our editors and team members for their invaluable expertise and dedicated efforts in creating this! Jeffrey Gimble, Trivia Frazier, PhD, MBA, Bruce Bunnell, Cecilia Sanchez, PhD Access the book here: https://lnkd.in/gpkqaCDz
To view or add a comment, sign in
-
-
We're barely scratching the surface of the potential clinical benefit of iPSCs. But they're extremely difficult to work with. A new platform called FAST-STEM aims to reduce "the time to generate ‘differentiation ready’ stem cell lines from several weeks to 5 days." Interesting academic community effort involving "eight different cell types across nine different laboratories." I wonder how this compares to the current speed within iPSC companies like bit.bio Full preprint from the Garton Lab at the University of Toronto here: https://lnkd.in/gW552e59
To view or add a comment, sign in
-
-
🔬 Exciting Research Alert! 🔬 This month, we’re excited to spotlight STEMCELL Technologies' latest breakthroughs in human induced pluripotent stem cells (#iPSCs) line generation. Standing at the forefront of #biomedicalresearch, human iPSCs offer unparalleled potential in disease modeling, drug discovery, and regenerative medicine. However, reproducible research with human iPSCs depends on thoroughly characterized and quality-controlled iPSC lines and cell banks. Unlock your research potential with STEMCELL’s latest article to understand some common challenges for iPSC users, the importance of standardizing data reporting and quality control measures, and ways to address these challenges for the best chance of success for your research goals. #ResearchExcellence #ScientificInnovation #ScientificAdvancements #SupplierOrchestration
To view or add a comment, sign in
-
-
Learn how to ensure reproducibility in research using human pluripotent stem cell models in this Science Exchange article: https://bit.ly/3VC6vg6
🔬 Exciting Research Alert! 🔬 This month, we’re excited to spotlight STEMCELL Technologies' latest breakthroughs in human induced pluripotent stem cells (#iPSCs) line generation. Standing at the forefront of #biomedicalresearch, human iPSCs offer unparalleled potential in disease modeling, drug discovery, and regenerative medicine. However, reproducible research with human iPSCs depends on thoroughly characterized and quality-controlled iPSC lines and cell banks. Unlock your research potential with STEMCELL’s latest article to understand some common challenges for iPSC users, the importance of standardizing data reporting and quality control measures, and ways to address these challenges for the best chance of success for your research goals. #ResearchExcellence #ScientificInnovation #ScientificAdvancements #SupplierOrchestration
To view or add a comment, sign in
-
-
Missed Dr. Sonja Mihailovic's expert insights on overcoming hiPSC reprogramming and differentiation challenges? Watch the webinar now: https://hubs.la/Q02JWBTH0 Dr. Mihailovic delves into the critical issues of inefficiency and reproducibility caused by manual manipulation in stem cell research. Discover how our innovative solution can: • Boost efficiency: Reduce cell heterogeneity. • Enhance survivability: Optimize cell health with conditioned culture environments. • Simplify workflows: Automate phenotypic selection and isolation. Watch webinar now to learn how to achieve consistent, reliable outcomes and accelerate your stem cell discoveries. #stemcellresearch #iPSCs #hiPSCreprogramming #hiPSCdifferentiation #CellRaft
To view or add a comment, sign in
-
-
📢 New Application Note! Stem cell research is complex, but sorting them doesn’t have to be. In this new comprehensive application note, we demonstrate the WOLF G2’s utility for: 🔵 Bulk sorting iPSCs with high viability (98% post sort!) and purity (1.6-fold increase) 🟢 Single cell isolation of iPSCs for clonal outgrowth with sustained pluripotency Check out the app note here: https://lnkd.in/g4PTvw9R #StemCells #iPSCs #GentleCellSorting
To view or add a comment, sign in
-